The global peripheral vascular devices market size is expected to reach USD 11,574.4 million by 2030, to expand at a CAGR of 7.4% from 2023 to 2030. One of the main factors propelling the expansion of this market for peripheral vascular devices and accessories is the rising prevalence of venous disorders or Chronic Venous Insufficiency (CVI). Its adoption is also being accelerated by the growing elderly population and the rising demand for minimally invasive endovascular operations, novel product launch, mergers, and collaborations by the key market players for business expansion are some of the factors that boosts the market growth.
IVC filters, hemodynamic flow alteration, EVAR stent-grafts, angiography catheters, and plague modification devices are some of the devices utilized in peripheral endovascular and coronary procedures as well as for treating peripheral arterial or coronary arterial disease. These tools are used during surgery to reduce patient interference with least amount of disruption. The market demand for peripheral vascular devices is significantly influenced by the rising need for less invasive procedures for the treatment of vascular disease. Patients are more likely to prefer minimally invasive procedures since they speed up or aid the healing process, lessen patient trauma, and necessitate shorter hospital stays.
For instance, in February 2020 , HonorHealth, a premier healthcare provider in the Valley that provides care to 1.6 million residents of the greater Phoenix area, announced today that its Cardiovascular Center of Excellence has made a significant advancement in the treatment of peripheral arterial disease (PAD). It is a common cardiovascular condition that affects more than 10 million people in the country. A patient with a completely blocked femoral artery underwent surgery as part of a DETOUR II clinical trial. The treatment was a percutaneous (skin puncture) bypass. Up to 200 patients were accepted for the research, which might result in FDA approval for the treatment. Without cutting open or making incisions in the leg, a peripheral percutaneous bypass procedure was conducted on a patient with advanced PAD. This makes such surgery minimal invasive and possibly riskier than the conventional approach. The DETOUR II treatment involved the use of stent grafts that run via the femoral vein, bypassing the damag
ed section of the femoral artery and, in essence, providing a bypass so that blood can flow freely to the patient's lower limb once more.
Moreover, minimally invasive procedures tend to minimize the post-surgery complications and reduce the mortality rates. Some of these procedures including balloon angioplasty, drug-eluting technologies, excisional atherectomy or laser ablation are significant in improving quality of life. As a result, these advantages are anticipated to raise market demand for peripheral vascular devices.
Increased patient awareness and healthcare spending, as well as higher acceptance rates of minimally invasive surgery, all contribute to its significant market share. In addition, the industry as a whole is anticipated to benefit from the rapid expansion of healthcare infrastructure and rising healthcare spending in emerging regions. Moreover, novel product launches by the key players boost the market. For instance, in January 2022 , a new drug-eluting stent for below the knee (BTK) manufactured by Cook Medical was given Breakthrough Device classification by the US Food and Drug Administration (FDA). This innovation is meant to treat patients with persistent ischemia that poses a hazard to their limbs.
The COVID-19 pandemic had a negative impact on elective treatment, surgeries and the diagnostic procedures. As per the research studies, people having cardiac disorders were more prone of getting infected with SARS-CoV-2 virus. For instance, as per the research article ‘Impact of COVID-19 on cardiac procedure activity in England and 30-day mortality’ by National Center for Biotechnology Information published in May 2021 , the cardiac surgeries and procedure rate was decreased by
45,000 surgeries with no risk of mortality during COVID-10 pandemic in England. Therefore, the cardiology sector had a negative impact of COVID-19 pandemic.
Moreover, the requirement for arterial blockage therapy for patients with cardiac diseases has resulted in the rise in emergency and critical care admissions, and this is what is anticipated to fuel the expansion of the market for peripheral vascular devices throughout the course of the analysis period. Also, the increasing demand for minimal invasive procedures and increasing incidence of PAD boost the peripheral vascular devices market.
This product will be delivered within 1-3 business days.
IVC filters, hemodynamic flow alteration, EVAR stent-grafts, angiography catheters, and plague modification devices are some of the devices utilized in peripheral endovascular and coronary procedures as well as for treating peripheral arterial or coronary arterial disease. These tools are used during surgery to reduce patient interference with least amount of disruption. The market demand for peripheral vascular devices is significantly influenced by the rising need for less invasive procedures for the treatment of vascular disease. Patients are more likely to prefer minimally invasive procedures since they speed up or aid the healing process, lessen patient trauma, and necessitate shorter hospital stays.
For instance, in February 2020 , HonorHealth, a premier healthcare provider in the Valley that provides care to 1.6 million residents of the greater Phoenix area, announced today that its Cardiovascular Center of Excellence has made a significant advancement in the treatment of peripheral arterial disease (PAD). It is a common cardiovascular condition that affects more than 10 million people in the country. A patient with a completely blocked femoral artery underwent surgery as part of a DETOUR II clinical trial. The treatment was a percutaneous (skin puncture) bypass. Up to 200 patients were accepted for the research, which might result in FDA approval for the treatment. Without cutting open or making incisions in the leg, a peripheral percutaneous bypass procedure was conducted on a patient with advanced PAD. This makes such surgery minimal invasive and possibly riskier than the conventional approach. The DETOUR II treatment involved the use of stent grafts that run via the femoral vein, bypassing the damag
ed section of the femoral artery and, in essence, providing a bypass so that blood can flow freely to the patient's lower limb once more.
Moreover, minimally invasive procedures tend to minimize the post-surgery complications and reduce the mortality rates. Some of these procedures including balloon angioplasty, drug-eluting technologies, excisional atherectomy or laser ablation are significant in improving quality of life. As a result, these advantages are anticipated to raise market demand for peripheral vascular devices.
Increased patient awareness and healthcare spending, as well as higher acceptance rates of minimally invasive surgery, all contribute to its significant market share. In addition, the industry as a whole is anticipated to benefit from the rapid expansion of healthcare infrastructure and rising healthcare spending in emerging regions. Moreover, novel product launches by the key players boost the market. For instance, in January 2022 , a new drug-eluting stent for below the knee (BTK) manufactured by Cook Medical was given Breakthrough Device classification by the US Food and Drug Administration (FDA). This innovation is meant to treat patients with persistent ischemia that poses a hazard to their limbs.
The COVID-19 pandemic had a negative impact on elective treatment, surgeries and the diagnostic procedures. As per the research studies, people having cardiac disorders were more prone of getting infected with SARS-CoV-2 virus. For instance, as per the research article ‘Impact of COVID-19 on cardiac procedure activity in England and 30-day mortality’ by National Center for Biotechnology Information published in May 2021 , the cardiac surgeries and procedure rate was decreased by
45,000 surgeries with no risk of mortality during COVID-10 pandemic in England. Therefore, the cardiology sector had a negative impact of COVID-19 pandemic.
Moreover, the requirement for arterial blockage therapy for patients with cardiac diseases has resulted in the rise in emergency and critical care admissions, and this is what is anticipated to fuel the expansion of the market for peripheral vascular devices throughout the course of the analysis period. Also, the increasing demand for minimal invasive procedures and increasing incidence of PAD boost the peripheral vascular devices market.
Peripheral Vascular Devices Market Report Highlights
- In 2022, the peripheral stents segment held majority share of 25.7% owing to the improvements in stent technology and the rising adoption of less invasive procedures.
- The peripheral accessories segment is anticipated to grow at a fastest rate over the forecast period. This is due to the presence of larger number of suppliers of peripheral accessories in the market as well as developing countries such as India and China offering low-cost supplies for these products. In addition to this, there is increasing demand for balloon inflation devices used for balloon angioplasty owing to the less risk and complications post-surgery, which is further driving the market.
- North America held the largest share of 39.7% in 2022. The market is driven by factors like the rising prevalence of cardiovascular disorders and the growing elderly population.
- Asia Pacific is anticipated to witness fastest growth over the forecast period. This is due to the increased public awareness of the need for prompt diagnosis and treatment, as well as improvements in peripheral vascular and cardiology technology in the region.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. Methodology
1.5. Research Scope and Assumptions
1.6. Market Formulation & Validation
1.6.1. Country Market: CAGR Calculation
1.7. Country Based Segment Share Calculation
1.8. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional Insights
2.4. Competitive Insights
2.5. Peripheral Vascular Devices Market Snapshot
2.6. Peripheral Vascular Devices Market Segment Snapshot
2.7. Peripheral Vascular Devices Market Competitive Landscape Snapshot
Chapter 3. Peripheral Vascular Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge
3.3. Peripheral Vascular Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.4. Impact of COVID-19 on Peripheral Vascular Devices Market
Chapter 4. Peripheral Vascular Devices Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Peripheral Vascular Devices Market: Type Movement Analysis, 2022 & 2030 (USD Million)
4.3. Peripheral Stents
4.3.1. Peripheral Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.1 Iliac Artery Stents
4.3.1.1.1 Iliac Artery Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.2 Femoral Artery Stents
4.3.1.2.1 Femoral Artery Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.3 Carotid Artery Stents
4.3.1.3.1 Carotid Artery Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.4 Renal Artery Stents
4.3.1.4.1 Renal Artery Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.5 Other Peripheral Stents
4.3.1.5.1 Other Peripheral Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. PTA Balloons
4.4.1. PTA Balloons Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Catheters
4.5.1. Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.1. Angiography Catheters
4.5.1.1.1. Angiography Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.2. Guiding Catheters
4.5.1.2.1. Guiding Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.3. IVUS/OCT Catheters
4.5.1.3.1. IVUS/OCT Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Endovascular Aneurysm Repair Stent Grafts
4.6.1. Endovascular Aneurysm Repair Stent Grafts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.1.1. Thoracic Endovascular Aneurysm Stent Grafts
4.6.1.1.1. Thoracic Endovascular Aneurysm Stent Grafts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.1.2. Abdominal Endovascular Aneurysm Stent Grafts
4.6.1.2.1. Abdominal Endovascular Aneurysm Stent Grafts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Plaque Modification Devices
4.7.1. Plaque Modification Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.1.1. Atherectomy Devices
4.7.1.1.1. Atherectomy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.1.2. Thrombectomy Devices
4.7.1.2.1. Thrombectomy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Peripheral Accessories
4.8.1. Peripheral Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.1.1. Guidewires
4.8.1.1.1. Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.1.1.2. Workhorse Guidewires
4.8.1.1.3. Workhorse Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.1.1.4. Specialty Guidewires
4.8.1.1.5. Specialty Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.1.1.6. Extra Support Guidewires
4.8.1.1.7. Extra Support Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.1.1.8. Frontline Finesse Guidewires
4.8.1.1.9. Frontline Finesse Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.1.2. Peripheral Vascular Closure Devices
4.8.1.2.1. Peripheral Vascular Closure Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.1.3. Balloon Inflation Devices
4.8.1.3.1. Balloon Inflation Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.1.4. Introducer Sheaths
4.8.1.4.1. Introducer Sheaths Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Inferior Vena Cava Filters
4.9.1. Inferior Vena Cava Filters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.1.1. Permanent Filters
4.9.1.1.1. Permanent Filters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.1.2. Retrievable Filters
4.9.1.2.1. Retrievable Filters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10. Hemodynamic Flow Alteration Devices
4.10.1. Hemodynamic Flow Alteration Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10.1.1. Chronic Total Occlusion Devices
4.10.1.1.1. Chronic Total Occlusion Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10.1.2. Embolic Protection Devices
4.10.1.2.1. Embolic Protection Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Peripheral Vascular Devices Market: Regional Estimates & Trend Analysis
5.1. Peripheral Vascular Devices Market Share, By Region, 2022 & 2030 (USD Million)
5.2. North America
5.2.1. North America Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Canada Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.2. U.K.
5.3.2.1. U.K. Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Germany Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. France Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Italy Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Spain Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.7. Denmark
5.3.7.1. Denmark Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.8. Norway
5.3.8.1. Norway Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.9. Sweden
5.3.9.1. Sweden Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2. China
5.4.2.1. China Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.3. Japan
5.4.3.1. Japan Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.4. India
5.4.4.1. India Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.5. Thailand
5.4.5.1. Thailand Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.6. South Korea
5.4.6.1. South Korea Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.7. Australia
5.4.7.1. Australia Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.3. Mexico
5.5.3.1. Mexico Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.4. Argentina
5.5.4.1. Argentina Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.2. South Africa
5.6.2.1. South Africa Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.4. UAE
5.6.4.1. UAE Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Kuwait Peripheral Vascular Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Company Market Share Analysis, 2022
6.3. Strategy Mapping
6.4. Company Profiles/Listing
6.4.1. Abbott Laboratories
6.4.1.1. Overview
6.4.1.2. Financial Performance (Net Revenue)
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. Angioscore Inc.
6.4.2.1. Overview
6.4.2.2. Financial Performance (Net Revenue)
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Edward Lifesciences Corporation
6.4.3.1. Overview
6.4.3.2. Financial Performance (Net Revenue)
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. Medtronic Inc.
6.4.4.1. Overview
6.4.4.2. Financial Performance (Net Revenue)
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. St. Jude Medical
6.4.5.1. Overview
6.4.5.2. Financial Performance (Net Revenue)
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. Teleflex Medical
6.4.6.1. Overview
6.4.6.2. Financial Performance (Net Revenue)
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Volcano Corporation
6.4.7.1. Overview
6.4.7.2. Financial Performance (Net Revenue)
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. Boston Scientific Corporation
6.4.8.1. Overview
6.4.8.2. Financial Performance (Net Revenue)
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiatives
6.4.9. Teleflex Medical
6.4.9.1. Overview
6.4.9.2. Financial Performance (Net Revenue)
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic Initiatives
6.4.10. Cook Group Inc.
6.4.10.1. Overview
6.4.10.2. Financial Performance (Net Revenue)
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic Initiatives
6.4.11. Cordis Corporation
6.4.11.1. Overview
6.4.11.2. Financial Performance (Net Revenue)
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic Initiatives
6.4.12. Covidien
6.4.12.1. Overview
6.4.12.2. Financial Performance (Net Revenue)
6.4.12.3. Product Benchmarking
6.4.12.4. Strategic Initiatives
6.4.13. W.L. Gore and Associates Ltd.
6.4.13.1. Overview
6.4.13.2. Financial Performance (Net Revenue)
6.4.13.3. Product Benchmarking
6.4.13.4. Strategic Initiatives
List of Tables
Table 1 Healthcare Expenditure (% of GDP)
Table 2 Key companies launching new products/services
Table 3 Key companies acquisition
Table 4 North America peripheral vascular devices market by country, 2018 - 2030 (USD Million)
Table 5 North America peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 6 U.S. peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 7 Canada peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 8 Europe peripheral vascular devices market by country, 2018 - 2030 (USD Million)
Table 9 Europe peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 10 Germany peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 11 U.K. peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 12 France peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 13 Italy peripheral vascular devices market by Type, 2018 - 2030 (USD Million)
Table 14 Spain peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 15 Denmark peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 16 Sweden peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 17 Norway peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 18 Asia Pacific peripheral vascular devices market by country, 2018 - 2030 (USD Million)
Table 19 Asia Pacific peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 20 Japan peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 21 China peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 22 India peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 23 South Korea peripheral vascular devices market by Type, 2018 - 2030 (USD Million)
Table 24 Australia peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 25 Thailand peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 26 Latin America peripheral vascular devices market by country, 2018 - 2030 (USD Million)
Table 27 Latin America peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 28 Brazil peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 29 Mexico peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 30 Argentina peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 31 MEA peripheral vascular devices market by country, 2018 - 2030 (USD Million)
Table 32 MEA peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 33 South Africa peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 34 Saudi Arabia peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 35 UAE peripheral vascular devices market by type, 2018 - 2030 (USD Million)
Table 36 Kuwait peripheral vascular devices market by Type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Peripheral Vascular Devices Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Parent market analysis
Fig. 9 Patient-population model
Fig. 10 Market formulation & validation
Fig. 11 Peripheral Vascular Devices Market snapshot
Fig. 12 Peripheral Vascular Devices Market segment snapshot
Fig. 13 Peripheral Vascular Devices Market competitive landscape snapshot
Fig. 14 Market research process
Fig. 15 Market driver relevance analysis (Current & future impact)
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 Peripheral Vascular Devices Market, Type outlook key takeaways (USD Million)
Fig. 18 Peripheral Vascular Devices Market: Type movement analysis 2022 & 2030 (USD Million)
Fig. 19 Peripheral Stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 PTA balloons market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Endovascular aneurysm repair stent grafts market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Plaque modification devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Peripheral accessories market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Inferior vena cava filters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Hemodynamic flow alteration devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Iliac artery stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Femoral artery stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Carotid artery stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Renal artery stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Other peripheral stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Angiography catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Guiding catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 IVUS/OCT catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Thoracic endovascular aneurysm stent grafts market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Abdominal endovascular aneurysm stent grafts market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Atherectomy devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Thrombectomy devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Guidewires market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Peripheral vascular closure devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Balloon inflation devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Introducer sheaths market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Workhorse guidewires market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Specialty guidewires market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Extra Support guidewires market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Frontline finesse guidewires market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Permanent filters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Retrievable filters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Chronic total occlusion devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Embolic protection devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Regional marketplace: Key takeaways
Fig. 52 Peripheral vascular devices market: Regional outlook, 2022 & 2030, USD Million
Fig. 53 North America peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 U.S. peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Canada peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Europe peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 U.K. peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Germany peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 France peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Italy peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Spain peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Denmark peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Norway peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Sweden peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Asia Pacific peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Japan peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 China peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 India peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Thailand peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 South Korea peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Australia peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Latin America peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Brazil peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Mexico peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Argentina peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 MEA peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 South Africa peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Saudi Arabia peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 UAE peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Kuwait peripheral vascular devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Strategy framework
Fig. 82 Heat map, 2021/2022
Companies Mentioned
- Abbott Laboratories
- Angioscore Inc.
- Edward Lifesciences Corporation
- Medtronic Inc.
- St. Jude Medical
- Teleflex Medical
- Volcano Corporation
- Boston Scientific Corporation
- Teleflex Medical
- Cook Group Inc.
- Cordis Corporation
- Covidien
- W.L. Gore and Associates Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 190 |
| Published | March 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 6500 Million |
| Forecasted Market Value ( USD | $ 11574.4 Million |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
